Kenya has signed six grants totalling $462 million to support programmes targeting HIV, tuberculosis and malaria.

In a statement issued in Nairobi, the Kenyan capital, the Ministry of Health said that the three-year grants from the Global Fund, an international financing and partnership organisation, will also strengthen health and community systems from July 2024 to June 2027.

“The total amount for each component includes $232.5 million for HIV, $72.9 million for malaria, $67.7 million for tuberculosis, and $34.6 million for health system strengthening,” the ministry said.

The Global Fund is a worldwide movement to defeat HIV/AIDS, tuberculosis and malaria.

In Kenya, the fund has supported the provision of HIV test kits and antiretroviral drugs to about 1.4 million people.

According to the Ministry of Health, this has led to a significant decline in new HIV infections by 78 per cent, HIV-related deaths by 68 per cent and mother-to-child transmissions by 65 per cent.

“Regarding the tuberculosis programme, we have recorded a treatment success rate of 86 per cent,” said the health ministry.

The ministry reported that the positivity rate among tuberculosis cases declined from 7.35 per cent in 2021 to 5.6 per cent in 2024.

The ministry added that the malaria programme contributed to an overall reduction in the disease burden, with the national prevalence level declining from 8.2 per cent in 2025 to 6 per cent in 2023.

It aims to reduce malaria incidence and deaths by at least 75 per cent by 2027.

The new grants will enhance quality care and prevention services for people with tuberculosis, leprosy, and lung diseases.

It has also contributed to achieving universal health coverage through comprehensive HIV prevention, treatment and care.

According to the Global Fund, it invests over $5 billion annually to fight HIV, tuberculosis and malaria, ensuring a healthier, safer and more equitable future for all.

(Xinhua/NAN)